These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 26535987

  • 1. Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining.
    Strickland S, Wasserman JK, Giassi A, Djordjevic B, Parra-Herran C.
    Int J Gynecol Pathol; 2016 May; 35(3):191-208. PubMed ID: 26535987
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours.
    Strickland S, Parra-Herran C.
    Histopathology; 2016 Jun; 68(7):977-87. PubMed ID: 26542609
    [Abstract] [Full Text] [Related]

  • 3. The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic.
    Perez Montiel D, Arispe Angulo K, Cantú-de León D, Bornstein Quevedo L, Chanona Vilchis J, Herrera Montalvo L.
    Ann Diagn Pathol; 2015 Aug; 19(4):249-52. PubMed ID: 26059401
    [Abstract] [Full Text] [Related]

  • 4. A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.
    Meagher NS, Wang L, Rambau PF, Intermaggio MP, Huntsman DG, Wilkens LR, El-Bahrawy MA, Ness RB, Odunsi K, Steed H, Herpel E, Anglesio MS, Zhang B, Lambie N, Swerdlow AJ, Lubiński J, Vierkant RA, Goode EL, Menon U, Toloczko-Grabarek A, Oszurek O, Bilic S, Talhouk A, García-Closas M, Wang Q, Tan A, Farrell R, Kennedy CJ, Jimenez-Linan M, Sundfeldt K, Etter JL, Menkiszak J, Goodman MT, Klonowski P, Leung Y, Winham SJ, Moysich KB, Behrens S, Kluz T, Edwards RP, Gronwald J, Modugno F, Hernandez BY, Chow C, Kelemen LE, Keeney GL, Carney ME, Natanzon Y, Robertson G, Sharma R, Gayther SA, Alsop J, Luk H, Karpinskyj C, Campbell I, Sinn P, Gentry-Maharaj A, Coulson P, Chang-Claude J, Shah M, Widschwendter M, Tang K, Schoemaker MJ, Koziak JM, Cook LS, Brenton JD, Daley F, Kristjansdottir B, Mateoiu C, Larson MC, Harnett PR, Jung A, deFazio A, Gorringe KL, Pharoah PDP, Minoo P, Stewart C, Bathe OF, Gui X, Cohen P, Ramus SJ, Köbel M.
    Mod Pathol; 2019 Dec; 32(12):1834-1846. PubMed ID: 31239549
    [Abstract] [Full Text] [Related]

  • 5. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
    Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT.
    Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622
    [Abstract] [Full Text] [Related]

  • 6. The utility of PAX8 and SATB2 immunohistochemical stains in distinguishing ovarian mucinous neoplasms from colonic and appendiceal mucinous neoplasm.
    Aldaoud N, Erashdi M, AlKhatib S, Abdo N, Al-Mohtaseb A, Graboski-Bauer A.
    BMC Res Notes; 2019 Nov 26; 12(1):770. PubMed ID: 31771640
    [Abstract] [Full Text] [Related]

  • 7. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary.
    Vang R, Gown AM, Zhao C, Barry TS, Isacson C, Richardson MS, Ronnett BM.
    Am J Surg Pathol; 2007 Jun 26; 31(6):854-69. PubMed ID: 17527072
    [Abstract] [Full Text] [Related]

  • 8. SATB2 is a supportive marker for the differentiation of a primary mucinous tumor of the ovary and an ovarian metastasis of a low-grade appendiceal mucinous neoplasm (LAMN): A series of seven cases.
    Schmoeckel E, Kirchner T, Mayr D.
    Pathol Res Pract; 2018 Mar 26; 214(3):426-430. PubMed ID: 29487003
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases.
    Vang R, Gown AM, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Ronnett BM.
    Am J Surg Pathol; 2006 Sep 26; 30(9):1130-9. PubMed ID: 16931958
    [Abstract] [Full Text] [Related]

  • 11. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
    Shin JH, Bae JH, Lee A, Jung CK, Yim HW, Park JS, Lee KY.
    Jpn J Clin Oncol; 2010 Mar 26; 40(3):208-13. PubMed ID: 19926591
    [Abstract] [Full Text] [Related]

  • 12. CDX2, SATB2, GATA3, TTF1, and PAX8 Immunohistochemistry in Krukenberg Tumors.
    Chiesa-Vottero A.
    Int J Gynecol Pathol; 2020 Mar 26; 39(2):170-177. PubMed ID: 32045390
    [Abstract] [Full Text] [Related]

  • 13. SATB2 Is Superior to CDX2 in Distinguishing Signet Ring Cell Carcinoma of the Upper Gastrointestinal Tract and Lower Gastrointestinal Tract.
    Ma C, Lowenthal BM, Pai RK.
    Am J Surg Pathol; 2018 Dec 26; 42(12):1715-1722. PubMed ID: 30212392
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours.
    Wang F, Yang Y, Du X, Zhu X, Hu Y, Lu C, Sui L, Zhao H, Song K, Yao Q.
    BMC Cancer; 2023 Jan 13; 23(1):44. PubMed ID: 36639622
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases.
    Malmros K, Lindholm A, Vidarsdottir H, Jirström K, Nodin B, Botling J, Mattsson JSM, Micke P, Planck M, Jönsson M, Staaf J, Brunnström H.
    Virchows Arch; 2024 Aug 13; 485(2):347-357. PubMed ID: 37349623
    [Abstract] [Full Text] [Related]

  • 17. Expression profile of mucins in ovarian mucinous tumors: distinguishing primary ovarian from metastatic tumors.
    Wang J, El-Bahrawy MA.
    Int J Gynecol Pathol; 2014 Mar 13; 33(2):166-75. PubMed ID: 24487472
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas.
    Ji H, Isacson C, Seidman JD, Kurman RJ, Ronnett BM.
    Int J Gynecol Pathol; 2002 Oct 13; 21(4):391-400. PubMed ID: 12352188
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic Utility of SATB2 in Metastatic Krukenberg Tumors of the Ovary: An Immunohistochemical Study of 70 Cases With Comparison to CDX2, CK7, CK20, Chromogranin, and Synaptophysin.
    Yang C, Sun L, Zhang L, Zhou L, Zhao M, Peng Y, Niu D, Li Z, Huang X, Kang Q, Jia L, Lai J, Cao D.
    Am J Surg Pathol; 2018 Feb 13; 42(2):160-171. PubMed ID: 28914716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.